Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
This guide weighs the advantages and drawbacks of target date versus lifecycle funds to help you pick the option that best fits your retirement plan.
25,428 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Bitcoin holds near $61,000 and Ether sits above $1,700 as softer jobs data cools rate-hike fears. Spot Bitcoin ETFs r...
Internal documents reveal OpenAI posted $21B in losses on $13B in revenue, signaling a costly push to scale AI at bre...
Dolly Parton sets Broadway marks a bold return after health setbacks, blending big dreams with big budgets. This arti...
Rising housing costs are nudging more noncollege-educated men back to the family home, a development economists say i...
A 66-year-old faces retirement with scant savings. The plan: clear debt, maximize Social Security, and tighten spendi...
Rising housing costs are reshaping life plans as couples delay marriage to save for a home. The market for first-time...
The price gap between gasoline and crude has widened, causing gasoline prices rising faster than oil at the pump even...
The 13F filings show billionaire david tepper goes big on Alphabet, Micron, and Meta, while dialing back on Alibaba a...
AppLovin reported its best quarter in history, with record revenue and an 84% EBITDA margin, but the stock declined s...
Strategy reports a modest bitcoin purchase from its treasury amid a mid-cap crypto pullback, lifting unrealized losse...
A veteran MIT roboticist who cofounded bankrupt robot iRobot cautions that Elon Musk's humanoid vision is not close t...